Elanco Animal Health Incorporated (ELAN) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Greenfield, IN, 미국. 현재 CEO는 Jeffrey N. Simmons.
ELAN 을(를) 보유 IPO 날짜 2018-09-20, 9,000 명의 정규직 직원, 에 상장 NYSE, 시가총액 $11.99B.
Elanco Animal Health Incorporated is a global animal health company that innovates, develops, manufactures, and markets pharmaceutical and nutritional products for both companion animals and farm animals. For pets, the company offers disease prevention products such as parasiticides and vaccines under brands including Seresto, Advantage, and Advantix, as well as therapeutic treatments for pain, osteoarthritis, and dermatological conditions. In the farm animal sector, Elanco provides vaccines, antibiotics, parasiticides, and nutritional health products for poultry, aquaculture, ruminant, and swine production, with key brands including Rumensin and Baytril. The company distributes its products through veterinarians, third-party distributors, and direct relationships with farm animal producers. Founded in 1954 and headquartered in Greenfield, Indiana, Elanco serves a diverse customer base spanning veterinary clinics and agricultural operations worldwide.
